Day: May 16, 2022

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Paclitaxel and Cisplatin in First-Line Treatment of Advanced or Distant Metastatic Esophageal Squamous Cell Carcinoma

–5th approved indication by NMPA significantly expands eligible patient population SHANGHAI, China, May 16, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (NMPA) has […]

Continue Reading »

CPO Fintech Platform Topwatch Achieves Significant Milestones

Blockchain authentication enabled from Topwatch with ORIGYN Luxury partnership. Topwatch to exceed R 1 billion in revenue for 2022. Total accumulated Assets Under Management (AUM) exceeds R 3 billion ($202 m). Twelve year anniversary since first transaction in 2010. Every Watch has a story – CAPE TOWN, South Africa, May 16, 2022 (GLOBE NEWSWIRE) […]

Continue Reading »

BluChip Launches an Innovative NFT Marketplace Uniquely Tethering the Value of Museum Artwork to NFTs

BluChip Pioneers the “Swappable” BluChip NFT Marketplace logo PALM SPRINGS, Calif., May 16, 2022 (GLOBE NEWSWIRE) — BluChip today introduced its unique platform enabling the purchase of non-fungible tokens (NFTs) that are tethered to an original fine art painting or sculpture. With this ability, NFTs now have actual physical value specific to world-class artwork, making them more […]

Continue Reading »

Crowdz Secures $10M Strategic Investment, Led by Citi and Global Cleantech Capital

The investment will enable Crowdz to expand its ability to bring accessible working capital to small businesses. Crowdz Blockchain Technology CAMPBELL, Calif., May 16, 2022 (GLOBE NEWSWIRE) — Small and mid-sized enterprise (SME) finance platform Crowdz has secured $10 million in investment, led by Citi and Global Cleantech Capital, with participation from Bold Capital Partners, […]

Continue Reading »

Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

May 16, 2022 Co-registration of real-time intravascular ultrasound and/or iFR physiological assessment data onto motion-compensated angiograms aids percutaneous coronary intervention (PCI) procedure planning, quantitative lesion measurement, stent choice and sizing, and therapy assessment Reduced need for contrast media enables broader access to PCI for patients at risk of acute kidney injury Ultra-low contrast PCI procedures […]

Continue Reading »

New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency

May 16, 2022 EchoNavigator 4.0 empowers heart teams with greater control of live fusion imaging plus new anatomical modeling and transseptal puncture guidance during minimally-invasive procedures Seamless integration and communication between Philips Ultrasound System – EPIQ CVxi – and Philips Image Guided Therapy System – Azurion – supports efficient fusion-imaging workflow for minimally-invasive treatment of […]

Continue Reading »

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration […]

Continue Reading »
Popular Posts
May 2022